image
Healthcare - Biotechnology - NASDAQ - US
$ 175.65
-2.01 %
$ 5.06 B
Market Cap
58.55
P/E
CASH FLOW STATEMENT
123 M OPERATING CASH FLOW
238.98%
-163 M INVESTING CASH FLOW
-197.78%
27 M FINANCING CASH FLOW
-86.68%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Krystal Biotech, Inc.
image
Net Income 89.2 M
Depreciation & Amortization 6.71 M
Capital Expenditures -4.24 M
Stock-Based Compensation 49.1 M
Change in Working Capital -14.5 M
Others 52 M
Free Cash Flow 119 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income 89.2 10.9 (140.0) (69.6) (32.2) (19.1) (10.9) (7.9) (1.1)
Depreciation & Amortization 6.7 5.0 4.1 2.8 1.9 0.7 0.1 23 K 2 K
Deferred Income Tax 0 0 0 0 0 0 0 0 0
Stock Based Compensation 49.1 39.9 33.2 15.3 3.3 1.2 0.8 0.2 33 K
Other Operating Activities (7.1) (106.8) (0.7) 1.5 33 K 67 K 1.0 3.3 7 K
Change in Working Capital (14.5) (37.9) 2.8 2.1 0.9 (1.7) 0.5 0.5 (0.2)
Cash From Operations 123.4 (88.8) (100.6) (47.9) (26.1) (18.7) (9.4) (3.9) (1.3)
INVESTING CASH FLOW
Capital Expenditures (4.2) (11.8) (53.0) (68.3) (14.8) (6.4) (2.2) (0.2) 15 K
Other Items (159.2) 94.4 (61.1) (158.4) 3.7 1.4 (8.1) 0 0
Cash From Investing Activities (163.4) 82.6 (114.1) (226.8) (11.2) (5.0) (10.3) (0.2) 15 K
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0 2.3 1.8
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 27.0 (0.7) (0.6) (8.0) 0 0 0 7.0 1.3
Cash From Financing Activities 27.0 202.8 35.3 347.7 118.0 107.5 73.8 51.8 3.2
CHANGE IN CASH
Net Change In Cash (13.5) 196.4 (179.3) 73.0 80.8 83.8 54.1 47.7 1.9
FREE CASH FLOW
Free Cash Flow 119.2 (100.6) (153.5) (116.3) (40.9) (25.1) (11.7) (4.1) (1.3)